Copyright Reports & Markets. All rights reserved.

Global Targeted Drug Delivery Device Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Targeted Drug Delivery Device Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Eye
    • 1.3.3 Brain
    • 1.3.4 Heart
    • 1.3.5 Breast
    • 1.3.6 Abdomen
    • 1.3.7 Others
  • 1.4 Market by Application
    • 1.4.1 Global Targeted Drug Delivery Device Market Share by Application: 2020 VS 2026
    • 1.4.2 Metabolic Disorder
    • 1.4.3 Ophthalmic Disease
    • 1.4.4 Oncological Disorder
    • 1.4.5 Neurological Disorder
    • 1.4.6 Cardiovascular Disorder
    • 1.4.7 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Targeted Drug Delivery Device Market Perspective (2015-2026)
  • 2.2 Targeted Drug Delivery Device Growth Trends by Regions
    • 2.2.1 Targeted Drug Delivery Device Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Targeted Drug Delivery Device Historic Market Share by Regions (2015-2020)
    • 2.2.3 Targeted Drug Delivery Device Forecasted Market Size by Regions (2021-2026)
  • 2.3 Targeted Drug Delivery Device Industry Dynamic
    • 2.3.1 Targeted Drug Delivery Device Market Trends
    • 2.3.2 Targeted Drug Delivery Device Market Drivers
    • 2.3.3 Targeted Drug Delivery Device Market Challenges
    • 2.3.4 Targeted Drug Delivery Device Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Targeted Drug Delivery Device Players by Market Size
    • 3.1.1 Global Top Targeted Drug Delivery Device Players by Revenue (2015-2020)
    • 3.1.2 Global Targeted Drug Delivery Device Revenue Market Share by Players (2015-2020)
  • 3.2 Global Targeted Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Targeted Drug Delivery Device Revenue
  • 3.4 Global Targeted Drug Delivery Device Market Concentration Ratio
    • 3.4.1 Global Targeted Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug Delivery Device Revenue in 2019
  • 3.5 Key Players Targeted Drug Delivery Device Area Served
  • 3.6 Key Players Targeted Drug Delivery Device Product Solution and Service
  • 3.7 Date of Enter into Targeted Drug Delivery Device Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Drug Delivery Device Breakdown Data by Type

  • 4.1 Global Targeted Drug Delivery Device Historic Market Size by Type (2015-2020)
  • 4.2 Global Targeted Drug Delivery Device Forecasted Market Size by Type (2021-2026)

5 Targeted Drug Delivery Device Breakdown Data by Application

  • 5.1 Global Targeted Drug Delivery Device Historic Market Size by Application (2015-2020)
  • 5.2 Global Targeted Drug Delivery Device Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Targeted Drug Delivery Device Market Size (2015-2026)
  • 6.2 North America Targeted Drug Delivery Device Market Size by Type (2015-2020)
  • 6.3 North America Targeted Drug Delivery Device Market Size by Application (2015-2020)
  • 6.4 North America Targeted Drug Delivery Device Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Targeted Drug Delivery Device Market Size (2015-2026)
  • 7.2 Europe Targeted Drug Delivery Device Market Size by Type (2015-2020)
  • 7.3 Europe Targeted Drug Delivery Device Market Size by Application (2015-2020)
  • 7.4 Europe Targeted Drug Delivery Device Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Targeted Drug Delivery Device Market Size (2015-2026)
  • 8.2 Asia-Pacific Targeted Drug Delivery Device Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Targeted Drug Delivery Device Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Targeted Drug Delivery Device Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Targeted Drug Delivery Device Market Size (2015-2026)
  • 9.2 Latin America Targeted Drug Delivery Device Market Size by Type (2015-2020)
  • 9.3 Latin America Targeted Drug Delivery Device Market Size by Application (2015-2020)
  • 9.4 Latin America Targeted Drug Delivery Device Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Targeted Drug Delivery Device Market Size (2015-2026)
  • 10.2 Middle East & Africa Targeted Drug Delivery Device Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Targeted Drug Delivery Device Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Targeted Drug Delivery Device Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 4D Molecular Therapeutics
    • 11.1.1 4D Molecular Therapeutics Company Details
    • 11.1.2 4D Molecular Therapeutics Business Overview
    • 11.1.3 4D Molecular Therapeutics Targeted Drug Delivery Device Introduction
    • 11.1.4 4D Molecular Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020))
    • 11.1.5 4D Molecular Therapeutics Recent Development
  • 11.2 AbbVie
    • 11.2.1 AbbVie Company Details
    • 11.2.2 AbbVie Business Overview
    • 11.2.3 AbbVie Targeted Drug Delivery Device Introduction
    • 11.2.4 AbbVie Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.2.5 AbbVie Recent Development
  • 11.3 Abeona Therapeutics
    • 11.3.1 Abeona Therapeutics Company Details
    • 11.3.2 Abeona Therapeutics Business Overview
    • 11.3.3 Abeona Therapeutics Targeted Drug Delivery Device Introduction
    • 11.3.4 Abeona Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.3.5 Abeona Therapeutics Recent Development
  • 11.4 Advaxis
    • 11.4.1 Advaxis Company Details
    • 11.4.2 Advaxis Business Overview
    • 11.4.3 Advaxis Targeted Drug Delivery Device Introduction
    • 11.4.4 Advaxis Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.4.5 Advaxis Recent Development
  • 11.5 Alcyone Lifesciences
    • 11.5.1 Alcyone Lifesciences Company Details
    • 11.5.2 Alcyone Lifesciences Business Overview
    • 11.5.3 Alcyone Lifesciences Targeted Drug Delivery Device Introduction
    • 11.5.4 Alcyone Lifesciences Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.5.5 Alcyone Lifesciences Recent Development
  • 11.6 AlphaVax
    • 11.6.1 AlphaVax Company Details
    • 11.6.2 AlphaVax Business Overview
    • 11.6.3 AlphaVax Targeted Drug Delivery Device Introduction
    • 11.6.4 AlphaVax Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.6.5 AlphaVax Recent Development
  • 11.7 Amgen
    • 11.7.1 Amgen Company Details
    • 11.7.2 Amgen Business Overview
    • 11.7.3 Amgen Targeted Drug Delivery Device Introduction
    • 11.7.4 Amgen Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.7.5 Amgen Recent Development
  • 11.8 Amicus Therapeutics
    • 11.8.1 Amicus Therapeutics Company Details
    • 11.8.2 Amicus Therapeutics Business Overview
    • 11.8.3 Amicus Therapeutics Targeted Drug Delivery Device Introduction
    • 11.8.4 Amicus Therapeutics Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.8.5 Amicus Therapeutics Recent Development
  • 11.9 Anaeropharma Science
    • 11.9.1 Anaeropharma Science Company Details
    • 11.9.2 Anaeropharma Science Business Overview
    • 11.9.3 Anaeropharma Science Targeted Drug Delivery Device Introduction
    • 11.9.4 Anaeropharma Science Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.9.5 Anaeropharma Science Recent Development
  • 11.10 AnGes
    • 11.10.1 AnGes Company Details
    • 11.10.2 AnGes Business Overview
    • 11.10.3 AnGes Targeted Drug Delivery Device Introduction
    • 11.10.4 AnGes Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 11.10.5 AnGes Recent Development
  • 11.11 AskBio
    • 10.11.1 AskBio Company Details
    • 10.11.2 AskBio Business Overview
    • 10.11.3 AskBio Targeted Drug Delivery Device Introduction
    • 10.11.4 AskBio Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.11.5 AskBio Recent Development
  • 11.12 Astellas Pharma
    • 10.12.1 Astellas Pharma Company Details
    • 10.12.2 Astellas Pharma Business Overview
    • 10.12.3 Astellas Pharma Targeted Drug Delivery Device Introduction
    • 10.12.4 Astellas Pharma Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.12.5 Astellas Pharma Recent Development
  • 11.13 AstraZeneca
    • 10.13.1 AstraZeneca Company Details
    • 10.13.2 AstraZeneca Business Overview
    • 10.13.3 AstraZeneca Targeted Drug Delivery Device Introduction
    • 10.13.4 AstraZeneca Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.13.5 AstraZeneca Recent Development
  • 11.14 Athersys
    • 10.14.1 Athersys Company Details
    • 10.14.2 Athersys Business Overview
    • 10.14.3 Athersys Targeted Drug Delivery Device Introduction
    • 10.14.4 Athersys Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.14.5 Athersys Recent Development
  • 11.15 BioCardia
    • 10.15.1 BioCardia Company Details
    • 10.15.2 BioCardia Business Overview
    • 10.15.3 BioCardia Targeted Drug Delivery Device Introduction
    • 10.15.4 BioCardia Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.15.5 BioCardia Recent Development
  • 11.16 Biogen
    • 10.16.1 Biogen Company Details
    • 10.16.2 Biogen Business Overview
    • 10.16.3 Biogen Targeted Drug Delivery Device Introduction
    • 10.16.4 Biogen Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.16.5 Biogen Recent Development
  • 11.17 BioInvent
    • 10.17.1 BioInvent Company Details
    • 10.17.2 BioInvent Business Overview
    • 10.17.3 BioInvent Targeted Drug Delivery Device Introduction
    • 10.17.4 BioInvent Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.17.5 BioInvent Recent Development
  • 11.18 BioRestorative Therapies
    • 10.18.1 BioRestorative Therapies Company Details
    • 10.18.2 BioRestorative Therapies Business Overview
    • 10.18.3 BioRestorative Therapies Targeted Drug Delivery Device Introduction
    • 10.18.4 BioRestorative Therapies Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.18.5 BioRestorative Therapies Recent Development
  • 11.19 bluebird bio
    • 10.19.1 bluebird bio Company Details
    • 10.19.2 bluebird bio Business Overview
    • 10.19.3 bluebird bio Targeted Drug Delivery Device Introduction
    • 10.19.4 bluebird bio Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.19.5 bluebird bio Recent Development
  • 11.20 Boston Scientific
    • 10.20.1 Boston Scientific Company Details
    • 10.20.2 Boston Scientific Business Overview
    • 10.20.3 Boston Scientific Targeted Drug Delivery Device Introduction
    • 10.20.4 Boston Scientific Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.20.5 Boston Scientific Recent Development
  • 11.21 CellProthera
    • 10.21.1 CellProthera Company Details
    • 10.21.2 CellProthera Business Overview
    • 10.21.3 CellProthera Targeted Drug Delivery Device Introduction
    • 10.21.4 CellProthera Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.21.5 CellProthera Recent Development
  • 11.22 Celsion
    • 10.22.1 Celsion Company Details
    • 10.22.2 Celsion Business Overview
    • 10.22.3 Celsion Targeted Drug Delivery Device Introduction
    • 10.22.4 Celsion Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.22.5 Celsion Recent Development
  • 11.23 Celyad
    • 10.23.1 Celyad Company Details
    • 10.23.2 Celyad Business Overview
    • 10.23.3 Celyad Targeted Drug Delivery Device Introduction
    • 10.23.4 Celyad Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.23.5 Celyad Recent Development
  • 11.24 Evonik
    • 10.24.1 Evonik Company Details
    • 10.24.2 Evonik Business Overview
    • 10.24.3 Evonik Targeted Drug Delivery Device Introduction
    • 10.24.4 Evonik Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.24.5 Evonik Recent Development
  • 11.25 Kadimastem
    • 10.25.1 Kadimastem Company Details
    • 10.25.2 Kadimastem Business Overview
    • 10.25.3 Kadimastem Targeted Drug Delivery Device Introduction
    • 10.25.4 Kadimastem Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.25.5 Kadimastem Recent Development
  • 11.26 Medtronic
    • 10.26.1 Medtronic Company Details
    • 10.26.2 Medtronic Business Overview
    • 10.26.3 Medtronic Targeted Drug Delivery Device Introduction
    • 10.26.4 Medtronic Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.26.5 Medtronic Recent Development
  • 11.27 Novartis
    • 10.27.1 Novartis Company Details
    • 10.27.2 Novartis Business Overview
    • 10.27.3 Novartis Targeted Drug Delivery Device Introduction
    • 10.27.4 Novartis Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.27.5 Novartis Recent Development
  • 11.28 Sanofi
    • 10.28.1 Sanofi Company Details
    • 10.28.2 Sanofi Business Overview
    • 10.28.3 Sanofi Targeted Drug Delivery Device Introduction
    • 10.28.4 Sanofi Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.28.5 Sanofi Recent Development
  • 11.29 SOTIO
    • 10.29.1 SOTIO Company Details
    • 10.29.2 SOTIO Business Overview
    • 10.29.3 SOTIO Targeted Drug Delivery Device Introduction
    • 10.29.4 SOTIO Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.29.5 SOTIO Recent Development
  • 11.30 Takeda
    • 10.30.1 Takeda Company Details
    • 10.30.2 Takeda Business Overview
    • 10.30.3 Takeda Targeted Drug Delivery Device Introduction
    • 10.30.4 Takeda Revenue in Targeted Drug Delivery Device Business (2015-2020)
    • 10.30.5 Takeda Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Targeted Drug Delivery Device market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Drug Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    by Target Organ
    Eye
    Brain
    Heart
    Breast
    Abdomen
    Others
    by Type of Biologic Delivered
    Cell
    Protein
    Enzyme
    Plasmid
    Antibody
    Small Peptide
    Modified RNA
    Growth Factor
    Neurotransmitter
    by Therapy Delivered
    Cell Therapy
    RNA Therapy
    Gene Therapy
    Immunotherapy
    Stem Cell Therapy

    Market segment by Application, split into
    Metabolic Disorder
    Ophthalmic Disease
    Oncological Disorder
    Neurological Disorder
    Cardiovascular Disorder
    Others

    Based on regional and country-level analysis, the Targeted Drug Delivery Device market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Targeted Drug Delivery Device market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    4D Molecular Therapeutics
    AbbVie
    Abeona Therapeutics
    Advaxis
    Alcyone Lifesciences
    AlphaVax
    Amgen
    Amicus Therapeutics
    Anaeropharma Science
    AnGes
    AskBio
    Astellas Pharma
    AstraZeneca
    Athersys
    BioCardia
    Biogen
    BioInvent
    BioRestorative Therapies
    bluebird bio
    Boston Scientific
    CellProthera
    Celsion
    Celyad
    Evonik
    Kadimastem
    Medtronic
    Novartis
    Sanofi
    SOTIO

    Buy now